| |
 |
OPIATES
(OPI)
Morphine
● Heroin ● Codeine ● Opium
QuickScreen™ One-Step Rapid
Drug Screen Test (Cassette type)

A
Professional, Forensic Diagnostic Test for use for the
Qualitative Detection of Opiates and Derivatives of Opium in Human
Urine at the Sensitivity Level of 2000 ng/ml Established as
the Revised Standard by the U.S. Department of Health and Human
Services, DOT, World Health Organization and
SAMHSA. |
|
INTENDED
USE
For a comprehensive
discussion on drug of abuse testing including typical detection time periods
see the DRUG
TESTING FAQ |
The QuickScreen™ One-Step Rapid Opiates Test is a rapid, visual, qualitative,
competitive binding immunoassay for the detection of Opiates: Morphine, codeine,
heroin, opium and their metabolites in human urine. The test provides a fast
confirmation of the presence of Opiates in the subject sample at a
minimum cutoff sensitivity level of 2000 ng/ml, the revised sensitivity level set by the
National Institute on Drug Abuse and Departments of Health and Human Services.
Note: Where indicated, any positive test should be confirmed using quantitative
methods by a qualified testing laboratory.
Note:
This assay provides only a preliminary analytical test
result. A more specific alternative chemical method such as high-pressure liquid
chromatography (HPLC) or Gas chromatography/mass spectrometry (GC/MS) must be used in
order to obtain a confirmed analytical result. For test situations requiring laboratory
confirmation by such methods please refer to the QuickScreen Pro At Home Test Kit. Clinical consideration and professional judgment should be applied to all
test results, particularly when preliminary positive results are indicated.
SUMMARY
AND EXPLANATION OF THE TEST
Opiates, often called narcotics, are analgesics (pain reducers) which work by depressing the central nervous system. They can also depress the respiratory system. Doctors often prescribe them for severe or chronic pain. Opiates are very addictive, both physically and psychologically. Use for only a short time
normally results in addiction. Some commonly used opiates are: Codeine, Darvon, Heroin, Methadone, Morphine, Opium, Percodan, Talwin, Dilaudid and Demerol. Opiates are commonly referred to as "downers"
. Opiates can appear in many forms: white powder or crystals; small white, yellow or orange pills; large colorful capsules; clear liquid and dark brown, sticky bars or balls. Heroin accounts for the majority of the illicit opiate abuse.
Some physical indications of opiate use include: extreme loss of appetite and weight, needle tracks or punctures, black and blue marks from "skin popping", scars along veins, cramps, nausea, vomiting, excessive scratching and complaint of itching,
excessive sweating, constipation, raw, red nostrils from snorting, runny nose, pin-point pupils and watery eyes, reduced vision, drowsiness, euphoria, trance-like states, excessive thirst, tremors, twitching, unkempt appearance, strong body odor, irritability, chills; slight hallucinations and lethargy. For
comprehensive information on drug testing including typical half-life or drug
detection periods see the Drug Testing FAQ.
The QuickScreen™ One-Step Rapid Opiates Test utilizes a unique combination of monoclonal antibodies to
selectively identify Opiates and their major metabolites in urine with a high degree of
sensitivity. The test kit is a rapid, visually read screening method that does not require
special instrumentation or training.
PRINCIPLE
The QuickScreen™ One-Step Rapid Opiates Test technology incorporates a chromatographic absorbent device in which the drug or drug metabolites in the sample compete with a Opiates derivative immobilized on a porous membrane for limited antibody sites. This is the preferred scientific method for qualitative assay. In the assay procedure, urine mixes with labeled antibody-dye conjugate and migrates through test device. When Opiates levels are below
2000 ng/ml (the detection cutoff sensitivity of the test) unbound antibody-dye conjugate binds to immobilized antigen conjugate in the Test Zone ("T"), producing a pink-rose colored band that indicates a negative result. Conversely, when Opiates levels are above the detection limit, antibody-dye conjugate binds to the free drug, forming an antigen-antibody-dye complex. The complex competes with immobilized antigen conjugate in the Test Zone, preventing the development of a pink-rose colored band. Regardless of the test result, a color band is produced in the Control Zone ("C") by a non-specific sandwich dye conjugate reaction. This band serves as a built-in quality control by demonstrating antibody recognition, verifying that the reagents are chemically active, and confirming that the test was performed correctly.
MATERIALS PROVIDED:
Test Device and Dropper Pipette
individually sealed in foil pouch with complete instructions.
ASSAY
PROCEDURE
-
Collect a urine sample from test subject using a suitable clean container preferably glass.
-
Refrigerated specimens or other materials should be equilibrated to room temperature before testing.
-
Open the foil pouch at the notch, remove the test device, and label the device with specimen ID.
-
Holding the dropper vertically as shown, add
4 drops of urine into the sample well "S"
waiting 5 seconds between drops.
-
Observe migration, or lateral flow of the sample across the entire test
panel. Add additional sample drops if migration is not complete.
-
Positive results may be observed as soon as
5 minutes, depending on the concentration of
Opiates in the tested specimen. To confirm negative results, a complete
reaction time of 8-10 minutes is required. Do not interpret results after
15 minutes.
INTERPRETATION
OF TEST RESULTS:
|
|
|
Negative
|
Positive
|
Invalid
|
The
development of two lines, a control line and a test line, in the test
result window indicates a negative test screen for the targeted drug or
drug metabolite.
|
The development of only one line, the
control line, in the test result window indicates a positive test screen
for the targeted drug or drug metabolite.
|
The
absence of a control line in the test result window indicates an invalid
test result regardless of the presence of a test line in the test result
window.
|
Positive: One (1) pink-rose band appears in the control zone and no band appears in the test zone. A positive result indicates the Opiates level is
2000 ng/ml or higher in the test urine sample.
Negative: One
band appears in the test zone and one band appears in the control zone. A negative result indicates that the Opiates level is below the detection sensitivity of
2000 ng/ml. IMPORTANT: any line, no matter how faint, appearing in the test area
confirms a negative test.
Invalid: If there are no distinct color bands visible in both the test zone
and the control zone or if there is a visible band in the test zone but not in the control
zone, then the test is invalid. In this instance, re-testing of the specimen is
recommended.
TEST
AVAILABILITY
The QuickScreen™ One-Step Rapid Opiates test is now available to professionals
and individuals concerned with Opium based drug (see
above) abuse.
The test is one-step, fast,
self-contained, individually packaged and can be performed any time the targeted
drug use or abuse is suspected. The tests come in order units of five (5)
individual tests at a cost per single diagnosis/screen of $4.00 for the minimum
order unit. For testing situations where sample adulteration is suspect, a
Rapid Urine Adulteration test is available.
Description |
Sale Unit |
Cost |
|
QuickScreen Rapid Opiates (OPI)
Test Cassette |
Five (5) Tests |
$19.90 |
 |
|
Fifteen (15) Tests |
$45.00 |
 |
|
Thirty
(30) Tests |
$75.00 |
 |
|
One Hundred
(100) Tests |
$190.00 |
 |
|
Two Hundred
Fifty
(250) Tests |
$375.00 |
 |
*If the
order buttons are absent or inoperable, please use the
pricing overview page to order. |

|